Key facts
- TORONTO DOMINION BANK filed SCHEDULE 13G/A for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK).
- Disclosed ownership: 5.4%.
- Date of event: 31 Mar 2026.
TORONTO DOMINION BANK - 31 Mar 2026 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)
- Filing Manager
- TORONTO DOMINION BANK
- Reporting Manager
- The Toronto-Dominion Bank
- Symbol
- STOK
- Shares outstanding
- 58,764,037 shares
- Disclosed Ownership
- 3,173,258 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 13:46:48 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Key filing fact
TORONTO DOMINION BANK disclosed 5.4% ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK) on 31 Mar 2026.
Change
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 15 May 2026, 13:46.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Toronto-Dominion Bank | 5.4% | 3,173,258 | 3,173,258 | 0 | Christina Petrou | Christina Petrou / Executive Vice President & Chief Operating Officer | |
| TD Securities Inc. | 0% | 2,300 | 2,300 | 0 | Greg Nowakowski | Greg Nowakowski / Chief Compliance Officer |
CIK / CUSIP context first